WO2024023715 - TOPICAL COMPOSITIONS AND USES THEREOF
National phase entry:
Publication Number
WO/2024/023715
Publication Date
01.02.2024
International Application No.
PCT/IB2023/057555
International Filing Date
26.07.2023
Title **
[English]
TOPICAL COMPOSITIONS AND USES THEREOF
[French]
COMPOSITIONS TOPIQUES ET LEURS UTILISATIONS
Applicants **
TRUETIVA INC.
KENNEDY, J. Phillip
Inventors
KENNEDY, J. Phillip
Priority Data
63/392,309
26.07.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2411 | |
| EPO | Filing, Examination, Granting | 14881 | |
| Japan | Filing, Examination, Granting | 2337 | |
| South Korea | Filing, Examination, Granting | 2432 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
26,801
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a topical composition comprising a cannabinoid, extracellular matrix component or extracellular matrix fragment, such as an extracellular polysaccharide that is hyaluronic acid, and a pharmaceutically acceptable carrier, excipient, diluent, reagent, or combinations thereof, and use thereof in the treatment skin disorders, muscle pain, and arthritic pain.[French]
La présente invention concerne une composition topique comprenant un cannabinoïde, un composant de matrice extracellulaire ou un fragment de matrice extracellulaire, tel qu'un polysaccharide extracellulaire qui est l'acide hyaluronique, et un véhicule, un excipient, un diluant, un réactif ou des combinaisons de ceux-ci, tous pharmaceutiquement acceptables , et leur utilisation dans le traitement de troubles cutanés, de la douleur musculaire et de la douleur arthritique.